What is Aerovate Therapeutics Inc. Common Stock's current stock price?

Aerovate Therapeutics Inc. Common Stock (AVTE) currently trades at USD 2.68. Track real-time price changes and historical performance on AllInvestView.

What is Aerovate Therapeutics Inc. Common Stock's dividend yield?

Aerovate Therapeutics Inc. Common Stock has a dividend yield of 89.55200000%. Track dividend payments and income with AllInvestView.

What sector is Aerovate Therapeutics Inc. Common Stock in?

Aerovate Therapeutics Inc. Common Stock operates in the Health Care sector. AllInvestView lets you analyze sector allocation across your entire portfolio.

Aerovate Therapeutics Inc. Common Stock AVTE · Stock Open Aerovate Therapeutics Inc. Common Stock in new tab

2.68 USD

Add to portfolio

EPS

-2.44

Yield

89.55%

Safety Score

P/B

1.05

ROE

-74.91

Beta

0.95

Target Price

2.33 USD

1M 6M YTD 1Y 2Y 5Y Max

Loading chart...

DCF Valuation

Tweak assumptions to recompute fair value for Aerovate Therapeutics Inc. Common Stock (AVTE)

Currency: USD

DCF Assumptions

Revenue growth (YoY) 0.10 Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).

EBITDA margin 0.30 Decimal (e.g., 0.30 = 30%).

Capex (% Revenue) 0.04 Decimal (e.g., 0.04 = 4%).

Tax rate 0.20 Decimal (e.g., 0.20 = 20%).

Terminal growth (g, %) 3% Percent number (e.g., 3 = 3%).

Cost of Equity (%) 10% Percent number (e.g., 10 = 10%).

Cost of Debt (%) 5% Percent number (e.g., 5 = 5%).

DCF Result

Fair Value (DCF)

—

Current Price

—

Upside

—

WACC

—

Terminal PV

—

Σ PV of FCFs

—

Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Aerovate Therapeutics Inc. Common Stock Analysis (AVTE)

United States Health Care Official Website Stock

Is Aerovate Therapeutics Inc. Common Stock a good investment? Aerovate Therapeutics Inc. Common Stock (AVTE) is currently trading at 2.68 USD. Market analysts have a consensus price target of 2.33 USD. This suggests the asset is currently trading above analyst expectations.

For income investors, Aerovate Therapeutics Inc. Common Stock pays a dividend yield of 89.55%.

Investor FAQ

Does Aerovate Therapeutics Inc. Common Stock pay a dividend?

Yes, it pays an annual dividend of 2.40 USD (89.55% yield).

What asset class is Aerovate Therapeutics Inc. Common Stock?

Aerovate Therapeutics Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

Aerovate Therapeutics, Inc., a biopharmaceutical company, engages in the treatment of pulmonary arterial hypertension in the United States. Aerovate Therapeutics, Inc., was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

Exchange Ticker

NMS (United States) AVTE

Trades

Dividend Yield

89.55%

Annual Dividends

2.40USD

Next Ex. Div Date

April 29, 2025

Dividend History paid per year (USD)

Historical Dividends

Year	Total Dividends
▸2025	2.40 USD
April 28, 2025	2.4000

Stock Splits

Split Date	Split Ratio to 1
April 29, 2025	0.03

Aerovate Therapeutics Inc. Common Stock AVTE · Stock Open Aerovate Therapeutics Inc. Common Stock in new tab

Key Metrics

Estimates

Dividend

DCF Valuation

DCF Assumptions

DCF Result

Explore Premium Features

Aerovate Therapeutics Inc. Common Stock Analysis (AVTE)

Investor FAQ

Company Profile

Fundamentals

Under Construction

Aerovate Therapeutics Inc. Common Stock AVTE · Stock Open Aerovate Therapeutics Inc. Common Stock in new tab

Key Metrics

Estimates

Dividend

DCF Valuation

DCF Assumptions

DCF Result

Explore Premium Features

Aerovate Therapeutics Inc. Common Stock Analysis (AVTE)

Investor FAQ

Company Profile

Explore Premium Features

Fundamentals

Under Construction

Community Discussion

Notifications